Diabetic chronic wounds are characterized by persistent hyperglycemia, oxidative stress, and inflammation. Glucose oxidase (GOx)-mediated glucose conversion showed potential in diabetic wound repair, however, the problem of oxygen consumption and subsequent cascaded ·OH release is still a challenge. Here, hollow Prussian blue (HPB) was prepared and used as a carrier to load GOx. Then it was coated with an EGCG-derived metal-phenolic network (MPN) to obtain a hybrid EGCG-GOx@HPB nanozyme. Compared with free GOx and GOx@HPB, EGCG-GOx@HPB showed enhanced stability against enzymatic degradation. And it not only lowered glucose levels, but also retained catalase (CAT)/superoxide dismutase (SOD) activity, while achieving continuous oxygen recycling and free radical scavenging. Further, advanced glycation end products (AGEs) accumulation was reduced. It protects endothelial cell mitochondrion function and promotes cell migration under high-glucose/high-ROS conditions in vitro. In diabetic full-thickness wounds, it accelerates wound closure, reduces inflammatory infiltration, and promotes vascular maturation by reducing oxidative stress and glucose metabolic pressure. It is a promising strategy for simultaneously hypoglycemic and antioxidant treatment in diabetic wounds therapy.